BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32522890)

  • 21. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Chen XJ; An N
    J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
    Li Y; Zhuang W; Huang M; Li X
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long noncoding RNA LINC01419 promotes hepatocellular carcinoma malignancy by mediating miR-485-5p/LSM4 axis.
    Sun ZP; Tan ZG; Peng C
    Kaohsiung J Med Sci; 2022 Sep; 38(9):826-838. PubMed ID: 35748489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of LINC01419 in regulating the cell stemness in lung adenocarcinoma through recruiting EZH2 and regulating FBP1 expression.
    Chen Z; Tang W; Zhou Y; He Z
    Biol Direct; 2022 Sep; 17(1):23. PubMed ID: 36050791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2.
    Yang S; Ruan X; Hu B; Tu J; Cai H
    Cell Tissue Res; 2023 Dec; 394(3):441-453. PubMed ID: 37851112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LINC01419 promotes cell proliferation and metastasis in lung adenocarcinoma via sponging miR-519b-3p to up-regulate RCCD1.
    Cheng Z; Hou S; Wu Y; Wang X; Sun Y; Liu B; Yuan M
    Biochem Biophys Res Commun; 2019 Nov; 520(1):107-114. PubMed ID: 31582214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal.
    Zhu P; Wang Y; Huang G; Ye B; Liu B; Wu J; Du Y; He L; Fan Z
    Nat Struct Mol Biol; 2016 Jul; 23(7):631-9. PubMed ID: 27239797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
    Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
    Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7.
    Di W; Weinan X; Xin L; Zhiwei Y; Xinyue G; Jinxue T; Mingqi L
    Cell Death Dis; 2019 Jul; 10(7):514. PubMed ID: 31273190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.
    Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S
    Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LINC01419 Promotes the Proliferation of Hepatoma Cells by Recruiting XRCC5 and Regulating Its Phosphorylation to Repair DNA Damage.
    Liu P; Zhang X; Fu Q; Liu C; Luo Q; Yu P; Chen S; Zhang H; Qin T
    Dis Markers; 2022; 2022():9313680. PubMed ID: 35903292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA FOXP4-AS1 facilitates the biological functions of hepatocellular carcinoma cells via downregulating ZC3H12D by mediating H3K27me3 through recruitment of EZH2.
    Ye J; Fu Y; Wang Z; Yu J
    Cell Biol Toxicol; 2022 Dec; 38(6):1047-1062. PubMed ID: 34545456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LINC00313 facilitates osteosarcoma carcinogenesis and metastasis through enhancing EZH2 mRNA stability and EZH2-mediated silence of PTEN expression.
    Xing CY; Zhang YZ; Hu W; Zhao LY
    Cell Mol Life Sci; 2022 Jun; 79(7):382. PubMed ID: 35751755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA SchLAH suppresses metastasis of hepatocellular carcinoma through interacting with fused in sarcoma.
    Ge Z; Cheng Z; Yang X; Huo X; Wang N; Wang H; Wang C; Gu D; Zhao F; Yao M; Fan J; Qin W
    Cancer Sci; 2017 Apr; 108(4):653-662. PubMed ID: 28196303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2.
    Wu Y; Hu L; Liang Y; Li J; Wang K; Chen X; Meng H; Guan X; Yang K; Bai Y
    Mol Cancer; 2017 Aug; 16(1):150. PubMed ID: 28854977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
    Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
    Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.